.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
McKesson
Medtronic
Queensland Health
Julphar
Merck
Federal Trade Commission
Moodys
Farmers Insurance
Boehringer Ingelheim

Generated: September 23, 2017

DrugPatentWatch Database Preview

Zydus Pharms Usa Inc Company Profile

« Back to Dashboard

What is the competitive landscape for ZYDUS PHARMS USA INC, and what generic and branded alternatives to ZYDUS PHARMS USA INC drugs are available?

ZYDUS PHARMS USA INC has one hundred and two approved drugs.

There are eight tentative approvals on ZYDUS PHARMS USA INC drugs.

Summary for Applicant: Zydus Pharms Usa Inc

Patents:0
Tradenames:91
Ingredients:91
NDAs:102
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa Inc
LAMOTRIGINE
lamotrigine
TABLET, CHEWABLE;ORAL078009-003Jan 22, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
TEMOZOLOMIDE
temozolomide
CAPSULE;ORAL206750-003Jul 31, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
VENLAFAXINE HYDROCHLORIDE
venlafaxine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL090174-002Apr 14, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
LEVOFLOXACIN
levofloxacin
TABLET;ORAL077652-002Sep 7, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
CLOPIDOGREL BISULFATE
clopidogrel bisulfate
TABLET;ORAL201686-001Oct 10, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
OXYBUTYNIN CHLORIDE
oxybutynin chloride
TABLET, EXTENDED RELEASE;ORAL202332-001Jun 26, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
PROPRANOLOL HYDROCHLORIDE
propranolol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL090321-001Mar 25, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
TOPIRAMATE
topiramate
TABLET;ORAL078235-003Mar 27, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
DIVALPROEX SODIUM
divalproex sodium
TABLET, EXTENDED RELEASE;ORAL078239-001Feb 27, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
DONEPEZIL HYDROCHLORIDE
donepezil hydrochloride
TABLET, ORALLY DISINTEGRATING;ORAL090175-001May 10, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for ZYDUS PHARMS USA INC drugs

Drugname Dosage Strength Tradename Submissiondate
omeprazole
Delayed-release Tablets20 mg
OMEPRAZOLE
6/3/2015

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Covington
Chinese Patent Office
Argus Health
Cipla
Accenture
Fuji
Boehringer Ingelheim
UBS
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot